Mount Vernon Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,008
| Closed | -$69K | – | 50 |
|
|
2019
Q3 | $69K | Sell |
10,008
-300
| -3% | -$2.07K | 0.1% | 49 |
|
|
2019
Q2 | $95K | Sell |
10,308
-500
| -5% | -$4.61K | 0.14% | 51 |
|
|
2019
Q1 | $169K | Buy |
10,808
+500
| +5% | +$7.82K | 0.26% | 50 |
|
|
2018
Q4 | $159K | Hold |
10,308
| – | – | 0.28% | 49 |
|
|
2018
Q3 | $222K | Sell |
10,308
-1,000
| -9% | -$21.5K | 0.33% | 48 |
|
|
2018
Q2 | $275K | Buy |
11,308
+851
| +8% | +$20.7K | 0.43% | 42 |
|
|
2018
Q1 | $179K | Sell |
10,457
-250
| -2% | -$4.28K | 0.28% | 49 |
|
|
2017
Q4 | $203K | Sell |
10,707
-1,166
| -10% | -$22.1K | 0.31% | 50 |
|
|
2017
Q3 | $209K | Sell |
11,873
-587
| -5% | -$10.3K | 0.35% | 51 |
|
|
2017
Q2 | $414K | Buy |
12,460
+2,144
| +21% | +$71.2K | 0.74% | 36 |
|
|
2017
Q1 | $331K | Sell |
10,316
-608
| -6% | -$19.5K | 0.61% | 40 |
|
|
2016
Q4 | $396K | Sell |
10,924
-200
| -2% | -$7.25K | 0.78% | 38 |
|
|
2016
Q3 | $512K | Sell |
11,124
-1,438
| -11% | -$66.2K | 1.06% | 36 |
|
|
2016
Q2 | $631K | Buy |
12,562
+619
| +5% | +$31.1K | 1.35% | 34 |
|
|
2016
Q1 | $639K | Sell |
11,943
-400
| -3% | -$21.4K | 1.42% | 34 |
|
|
2015
Q4 | $810K | Hold |
12,343
| – | – | 1.77% | 28 |
|
|
2015
Q3 | $697K | Buy |
12,343
+512
| +4% | +$28.9K | 1.62% | 28 |
|
|
2015
Q2 | $699K | Hold |
11,831
| – | – | 1.51% | 33 |
|
|
2015
Q1 | $737K | Buy |
11,831
+550
| +5% | +$34.3K | 1.59% | 33 |
|
|
2014
Q4 | $649K | Buy |
11,281
+350
| +3% | +$20.1K | 1.49% | 31 |
|
|
2014
Q3 | $588K | Buy |
10,931
+100
| +0.9% | +$5.38K | 1.46% | 33 |
|
|
2014
Q2 | $568K | Sell |
10,831
-50
| -0.5% | -$2.62K | 1.45% | 33 |
|
|
2014
Q1 | $575K | Sell |
10,881
-225
| -2% | -$11.9K | 1.5% | 33 |
|
|
2013
Q4 | $445K | Sell |
11,106
-650
| -6% | -$26K | 1.16% | 38 |
|
|
2013
Q3 | $444K | Sell |
11,756
-33,090
| -74% | -$1.25M | 1.35% | 34 |
|
|
2013
Q2 | $1.76M | Buy |
+44,846
| New | +$1.76M | 1.9% | 28 |
|